Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $6.54 Analyst target: $14.67 Upside: 124.31%
Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, develops gene therapy products to treat patients with eye diseases. The company is headquartered in Stevenage, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.